Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PABPC1 | P11940 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 6/20 | 0.34 |
| ▸ | RAB9A | P51151 | 5/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | PLK1 | P53350 | 2/20 | 0.32 |
| ▸ | PLK2 | Q9NYY3 | 2/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24443643 | 1.00 | PABPC1 (0.37) | PABPC1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL13525199 | 0.88 | PABPC1 (0.41) | PABPC1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL10046784 | 0.87 | PABPC1 (0.36) | PABPC1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL13525216 | 0.84 | CA12 (0.40) | PABPC1MEN1KMT2ALMNAMAPK1 | |
| SCHEMBL22699857 | 0.79 | MAPT (0.34) | PABPC1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL10782928 | 0.79 | PABPC1 (0.41) | PABPC1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL6125203 | 0.79 | MAPT (0.48) | MAPTRAB9AMEN1KMT2ANPC1 | |
| SCHEMBL13525209 | 0.76 | MEN1 (0.31) | MEN1KMT2ALMNAMAPK1GAA | |
| SCHEMBL13525222 | 0.75 | PABPC1 (0.36) | PABPC1MAPTRAB9AMEN1KMT2A | |
| SCHEMBL15039505 | 0.74 | DNM1 (0.41) | MAPTRAB9AMEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230346669-A1 | PROCESS FOR DYEING KERATIN FIBERS USING A DIRECT DYE AND A SACCHARINATE SALT AND COMPOSITION COMPRISING THEM | L'OREAL (FR) | 2023-11-02 | — | — | US | disclosed |
| US-20230346669-A1 | PROCESS FOR DYEING KERATIN FIBERS USING A DIRECT DYE AND A SACCHARINATE SALT AND COMPOSITION COMPRISING THEM | L'OREAL (FR) | 2023-11-02 | — | — | US | disclosed |
| US-20230310294-A1 | COMPOSITION FOR SIMULTANEOUS BLEACHING AND DYEING OF KERATIN FIBERS, COMPRISING A PARTICULAR HETEROCYCLIC SALT, AND PROCESS USING THIS COMPOSITION | L'OREAL (FR) | 2023-10-05 | — | — | US | disclosed |
| US-20230310294-A1 | COMPOSITION FOR SIMULTANEOUS BLEACHING AND DYEING OF KERATIN FIBERS, COMPRISING A PARTICULAR HETEROCYCLIC SALT, AND PROCESS USING THIS COMPOSITION | L'OREAL (FR) | 2023-10-05 | — | — | US | disclosed |
| US-11672747-B2 | Process for dyeing keratin materials using a direct dye and an aliphatic ammonium salt, and composition comprising same | L'OREAL (FR) | 2023-06-13 | — | — | US | disclosed |
| US-11672747-B2 | Process for dyeing keratin materials using a direct dye and an aliphatic ammonium salt, and composition comprising same | L'OREAL (FR) | 2023-06-13 | — | — | US | disclosed |
| US-20220183944-A1 | PROCESS FOR DYEING KERATIN MATERIALS USING A DIRECT DYE AND AN ALIPHATIC AMMONIUM SALT, AND COMPOSITION COMPRISING SAME | L'OREAL (FR) | 2022-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230346669-A1 | PROCESS FOR DYEING KERATIN FIBERS USING A DIRECT DYE AND A SACCHARINATE SALT AND COMPOSITION COMPRISING THEM | KRT18, DSG1, KRTCAP2 | PABPC1 2806/4885MAPT 355/4885RAB9A 3248/4885 |
| US-20230310294-A1 | COMPOSITION FOR SIMULTANEOUS BLEACHING AND DYEING OF KERATIN FIBERS, COMPRISING A PARTICULAR HETEROCYCLIC SALT, AND PROCESS USING THIS COMPOSITION | KRT18, KAT2B, SPIN2B | PABPC1 3926/4885MAPT 1259/4885RAB9A 1928/4885 |
| US-11672747-B2 | Process for dyeing keratin materials using a direct dye and an aliphatic ammonium salt, and composition comprising same | KRT18, MARK1, IK | PABPC1 2101/4885MAPT 465/4885RAB9A 3926/4885 |
| US-20220183944-A1 | PROCESS FOR DYEING KERATIN MATERIALS USING A DIRECT DYE AND AN ALIPHATIC AMMONIUM SALT, AND COMPOSITION COMPRISING SAME | KRT18, MARK1, IK | PABPC1 2101/4885MAPT 465/4885RAB9A 3926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.